A much awaited breakthrough for Dengue
The Director of the Dengue Research Center of the 麻豆视频传媒 Prof. Neelika Malavige was interviewed by the 鈥淎da鈥� newspaper on 27th February 2017 regarding its promising medical breakthrough in the field of dengue.
Speaking to the newspaper Prof. Neelika mentioned that the dengue hemorrhagic fever resulting in bleeding, low levels of blood platelets and especially blood plasma leakage is triggered by the Platelet Activating Factor (PAF) and that her teams鈥� objective was to find a drug that would control that particular factor. Accordingly they had imported the drug 鈥淩upatadine鈥� with special permission from the Health ministry in order to experiment with and their research concluded bringing many positive responses.
She and her team therefore are hopeful that this research would in the future bring about a truly miraculous drug to our nation which is indeed in dire need of one.
View article online at e-paper :聽聽(12th Page)
